BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16079149)

  • 1. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
    J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
    Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
    Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH; Rapti M; Knaüper V; Murphy G
    J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
    Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
    J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
    Wei S; Xie Z; Filenova E; Brew K
    Biochemistry; 2003 Oct; 42(42):12200-7. PubMed ID: 14567681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
    Lee MH; Verma V; Maskos K; Nath D; Knäuper V; Dodds P; Amour A; Murphy G
    Biochem J; 2002 May; 364(Pt 1):227-34. PubMed ID: 11988096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex.
    Wisniewska M; Goettig P; Maskos K; Belouski E; Winters D; Hecht R; Black R; Bode W
    J Mol Biol; 2008 Sep; 381(5):1307-19. PubMed ID: 18638486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2005 Apr; 280(16):15967-75. PubMed ID: 15713681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3.
    Lee MH; Verma V; Maskos K; Becherer JD; Knäuper V; Dodds P; Amour A; Murphy G
    FEBS Lett; 2002 Jun; 520(1-3):102-6. PubMed ID: 12044879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
    Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G
    FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1).
    Tsakadze NL; Sithu SD; Sen U; English WR; Murphy G; D'Souza SE
    J Biol Chem; 2006 Feb; 281(6):3157-64. PubMed ID: 16332693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
    Wei S; Chen Y; Chung L; Nagase H; Brew K
    J Biol Chem; 2003 Mar; 278(11):9831-4. PubMed ID: 12515831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2004 Oct; 279(43):45121-9. PubMed ID: 15308656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.
    Lee MH; Dodds P; Verma V; Maskos K; Knäuper V; Murphy G
    Biochem J; 2003 Apr; 371(Pt 2):369-76. PubMed ID: 12556225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.
    Walker EJ; Rosenberg GA
    Exp Neurol; 2009 Mar; 216(1):122-31. PubMed ID: 19111539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
    Kassiri Z; Oudit GY; Sanchez O; Dawood F; Mohammed FF; Nuttall RK; Edwards DR; Liu PP; Backx PH; Khokha R
    Circ Res; 2005 Aug; 97(4):380-90. PubMed ID: 16037568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
    Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
    J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice.
    Souza DG; Ferreira FL; Fagundes CT; Amaral FA; Vieira AT; Lisboa RA; Andrade MV; Trifilieff A; Teixeira MM
    Eur J Pharmacol; 2007 Sep; 571(1):72-80. PubMed ID: 17619015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
    Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.